Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study

PURPOSE: Regorafenib demonstrated encouraging results in recurrent glioblastoma patients. Some studies showed that changes in circulating thyroid hormones (fT3, fT4, fT3/fT4 ratio) can be considered as prognostic factors in patients with various types of tumors. We designed this study to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Caccese, Mario, Desideri, Isacco, Padovan, Marta, Bruno, Francesco, Cerretti, Giulia, Fiorentino, Alba, Denaro, Luca, Chioffi, Franco, Della Puppa, Alessandro, Maccari, Marta, Cavallin, Francesco, Coppola, Marina, Pittaro, Alice, Rudà, Roberta, Livi, Lorenzo, Lombardi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322943/
https://www.ncbi.nlm.nih.gov/pubmed/37264256
http://dx.doi.org/10.1007/s11060-023-04356-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322943/
https://www.ncbi.nlm.nih.gov/pubmed/37264256
http://dx.doi.org/10.1007/s11060-023-04356-w

Ejemplares similares